Liping Ai
Shenyang, 110004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis.
Journal: eLife
Published: September 10, 2025
Correction: Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer.
Journal: eLife
Published: May 08, 2025
Erratum to: FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Journal: Science China. Life sciences
Published: March 18, 2025
FSIP1 enhances the therapeutic sensitivity to CDK4/6 inhibitors in triple-negative breast cancer patients by activating the Nanog pathway.
Journal: Science China. Life sciences
Published: February 08, 2023
Binding blockade between TLN1 and integrin β1 represses triple-negative breast cancer.
Journal: eLife
Published: March 17, 2021
Association of human breast cancer CD44-/CD24- cells with delayed distant metastasis.
Journal: eLife
Published: December 03, 2020
Knockdown of endothelin receptor B inhibits the progression of triple-negative breast cancer.
Journal: Annals of the New York Academy of Sciences
Published: September 20, 2018
SND1 expression in breast cancer tumors is associated with poor prognosis.
Journal: Annals of the New York Academy of Sciences
Published: June 30, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026